1140 Labyrinthin as a potential neoantigen for oncogene-driven and non-oncogene-driven lung adenocarcinomas
| Main Authors: | , , , , , , |
|---|---|
| Format: | Article |
| Language: | English |
| Published: |
BMJ Publishing Group
2023-11-01
|
| Series: | Journal for ImmunoTherapy of Cancer |
| _version_ | 1797629787947139072 |
|---|---|
| author | Shuai Chen Tianhong Li Dennis J Montoya Siqi Long Kyra A Toomey Varun Viswanath Michael Babich |
| author_facet | Shuai Chen Tianhong Li Dennis J Montoya Siqi Long Kyra A Toomey Varun Viswanath Michael Babich |
| author_sort | Shuai Chen |
| collection | DOAJ |
| first_indexed | 2024-03-11T10:57:57Z |
| format | Article |
| id | doaj.art-25a3a980d58d4a4f837fd445fc7e356c |
| institution | Directory Open Access Journal |
| issn | 2051-1426 |
| language | English |
| last_indexed | 2024-03-11T10:57:57Z |
| publishDate | 2023-11-01 |
| publisher | BMJ Publishing Group |
| record_format | Article |
| series | Journal for ImmunoTherapy of Cancer |
| spelling | doaj.art-25a3a980d58d4a4f837fd445fc7e356c2023-11-13T03:10:07ZengBMJ Publishing GroupJournal for ImmunoTherapy of Cancer2051-14262023-11-0111Suppl 110.1136/jitc-2023-SITC2023.11401140 Labyrinthin as a potential neoantigen for oncogene-driven and non-oncogene-driven lung adenocarcinomasShuai Chen0Tianhong Li1Dennis J Montoya2Siqi Long3Kyra A Toomey4Varun Viswanath5Michael Babich64University of California, Davis, Sacramento, CA, USA20UC Davis Comprehensive Cancer Center, Sacramento, CA, USA1UC Davis Health, Sacramento, CA, USA3UC Davis Comprehensive Cancer Center, Sacramento, CA, USA2UCDMC Comprehensive Cancer Center, Sacramento, CA, USA2UCDMC Comprehensive Cancer Center, Sacramento, CA, USA5LabyRx Immuno-Oncology, Sacramento, CA, USA |
| spellingShingle | Shuai Chen Tianhong Li Dennis J Montoya Siqi Long Kyra A Toomey Varun Viswanath Michael Babich 1140 Labyrinthin as a potential neoantigen for oncogene-driven and non-oncogene-driven lung adenocarcinomas Journal for ImmunoTherapy of Cancer |
| title | 1140 Labyrinthin as a potential neoantigen for oncogene-driven and non-oncogene-driven lung adenocarcinomas |
| title_full | 1140 Labyrinthin as a potential neoantigen for oncogene-driven and non-oncogene-driven lung adenocarcinomas |
| title_fullStr | 1140 Labyrinthin as a potential neoantigen for oncogene-driven and non-oncogene-driven lung adenocarcinomas |
| title_full_unstemmed | 1140 Labyrinthin as a potential neoantigen for oncogene-driven and non-oncogene-driven lung adenocarcinomas |
| title_short | 1140 Labyrinthin as a potential neoantigen for oncogene-driven and non-oncogene-driven lung adenocarcinomas |
| title_sort | 1140 labyrinthin as a potential neoantigen for oncogene driven and non oncogene driven lung adenocarcinomas |
| work_keys_str_mv | AT shuaichen 1140labyrinthinasapotentialneoantigenforoncogenedrivenandnononcogenedrivenlungadenocarcinomas AT tianhongli 1140labyrinthinasapotentialneoantigenforoncogenedrivenandnononcogenedrivenlungadenocarcinomas AT dennisjmontoya 1140labyrinthinasapotentialneoantigenforoncogenedrivenandnononcogenedrivenlungadenocarcinomas AT siqilong 1140labyrinthinasapotentialneoantigenforoncogenedrivenandnononcogenedrivenlungadenocarcinomas AT kyraatoomey 1140labyrinthinasapotentialneoantigenforoncogenedrivenandnononcogenedrivenlungadenocarcinomas AT varunviswanath 1140labyrinthinasapotentialneoantigenforoncogenedrivenandnononcogenedrivenlungadenocarcinomas AT michaelbabich 1140labyrinthinasapotentialneoantigenforoncogenedrivenandnononcogenedrivenlungadenocarcinomas |